Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 0.25 Contact Hours.
Acknowledgment of Support
This activity is supported by an educational grant from Verastem, Inc.
Burst CME™ for the Onco-Nurse: Optimizing Patient Care in Follicular Lymphoma
Release Date: May 29, 2020
Expiration Date: May 29, 2021
Activity Overview
This brief online education activity is designed to provide information on the role of biomarkers in follicular lymphoma (FL) and the recent updates regarding treatment and care coordination among patients with FL. This activity is presented in a multimedia format that includes an audio interview with Dr Sandra Kurtin.
Acknowledgement of Support
This activity is supported by an educational grant from Verastem, Inc.
Instructions for This Activity and Receiving Credit
You may immediately download your certificate. |
Target Audience
This educational program is directed toward nurses and other healthcare professionals who manage patients with follicular lymphoma.
Learning Objectives
Upon successful completion of this educational activity, you should be better prepared to:
- Determine the evolving role of biomarkers in follicular lymphoma (FL)
- Assess practice-changing and recent evidence that informs treatment and care coordination among patients with FL.
Faculty, Staff, and Planners’ Disclosures
In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Faculty
Nurse Practitioner
The University of Arizona Cancer Center
Assistant Professor of Clinical Medicine
Adjunct Clinical Professor of Nursing
The University of Arizona
Disclosures: Consultant: BMS, Pharmacyclics, Amgen, Incyte, Abbvie.
The staff Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.
Off-Label Disclosure and Disclaimer
This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.
Login or Register to Start Activity
Please use the form below to Register or Log In to begin Activity.